SG Americas Securities LLC boosted its holdings in shares of The Beauty Health Company (NASDAQ:SKIN – Free Report) by 38.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,290 shares of the company’s stock after purchasing an additional 9,749 shares during the period. SG Americas Securities LLC’s holdings in Beauty Health were worth $56,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Sanctuary Advisors LLC acquired a new stake in Beauty Health during the second quarter valued at approximately $47,000. Orion Portfolio Solutions LLC acquired a new stake in Beauty Health during the third quarter valued at approximately $65,000. HighTower Advisors LLC acquired a new stake in Beauty Health during the third quarter valued at approximately $121,000. Atom Investors LP lifted its stake in Beauty Health by 19.7% during the third quarter. Atom Investors LP now owns 99,924 shares of the company’s stock valued at $144,000 after purchasing an additional 16,416 shares during the last quarter. Finally, Barclays PLC lifted its stake in Beauty Health by 224.7% during the third quarter. Barclays PLC now owns 106,103 shares of the company’s stock valued at $153,000 after purchasing an additional 73,425 shares during the last quarter. 93.26% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group increased their target price on shares of Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a research note on Wednesday, November 13th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Beauty Health presently has a consensus rating of “Hold” and an average price target of $2.55.
Beauty Health Stock Up 3.1 %
SKIN stock opened at $1.67 on Friday. The Beauty Health Company has a 52-week low of $0.91 and a 52-week high of $5.17. The company’s 50 day simple moving average is $1.61 and its 200-day simple moving average is $1.58. The company has a debt-to-equity ratio of 9.23, a current ratio of 6.56 and a quick ratio of 5.57. The firm has a market capitalization of $207.28 million, a P/E ratio of -3.98 and a beta of 0.82.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.
Further Reading
- Five stocks we like better than Beauty Health
- What is a Special Dividend?
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- How to Use the MarketBeat Dividend Calculator
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- How to Calculate Options Profits
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Want to see what other hedge funds are holding SKIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Beauty Health Company (NASDAQ:SKIN – Free Report).
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.